Recombinant multi-species TRIM26 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TRIM26 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. Although the function of the protein is unknown, the RING domain suggests that the protein may have DNA-binding activity. The gene localizes to the major histocompatibility complex (MHC) class I region on chromosome 6. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jun 2011]
The Alternative Names of target: AFP,Acid finger protein (AFP),RING finger protein 95,RNF95,TRIM26,Trim26,Tripartite motif-containing protein 26,ZNF173,Zfp173,Zfp1736,Zinc finger protein 173,Znf173

Target products collectionGo to TRIM26 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12022-Ag-1/ GM-Tg-hg-IP12022-Ag-2 Human TRIM26 protein Human
GM-Tg-rg-IP12022-Ag-1/ GM-Tg-rg-IP12022-Ag-2 Rat TRIM26 protein Rat
GM-Tg-mg-IP12022-Ag-1/ GM-Tg-mg-IP12022-Ag-2 Mouse TRIM26 protein Mouse
GM-Tg-cynog-IP12022-Ag-1/ GM-Tg-cynog-IP12022-Ag-2 Cynomolgus/Rhesus macaque TRIM26 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12022-Ag-1/ GM-Tg-felg-IP12022-Ag-2 Feline TRIM26 protein Feline
GM-Tg-cang-IP12022-Ag-1/ GM-Tg-cang-IP12022-Ag-2 Canine TRIM26 protein Canine
GM-Tg-bovg-IP12022-Ag-1/ GM-Tg-bovg-IP12022-Ag-2 Bovine TRIM26 protein Bovine
GM-Tg-equg-IP12022-Ag-1/ GM-Tg-equg-IP12022-Ag-2 Equine TRIM26 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12022-Ag-1/ GM-Tg-hg-IP12022-Ag-2; GM-Tg-rg-IP12022-Ag-1/ GM-Tg-rg-IP12022-Ag-2;
GM-Tg-mg-IP12022-Ag-1/ GM-Tg-mg-IP12022-Ag-2; GM-Tg-cynog-IP12022-Ag-1/ GM-Tg-cynog-IP12022-Ag-2;
GM-Tg-felg-IP12022-Ag-1/ GM-Tg-felg-IP12022-Ag-2; GM-Tg-cang-IP12022-Ag-1/ GM-Tg-cang-IP12022-Ag-2;
GM-Tg-bovg-IP12022-Ag-1/ GM-Tg-bovg-IP12022-Ag-2; GM-Tg-equg-IP12022-Ag-1/ GM-Tg-equg-IP12022-Ag-2
Products Name TRIM26 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name TRIM26
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TRIM26 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.